JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

<i>L.</i><i>interrogans</i> induces afadin degradation in infected RPTECs through different strain-dependent mechanisms. by Tetsuya Kakita (4922584)

Proteosomal and pan-caspase inhibitors differentially prevent the disruption of the epithelial cell barrier by the clinical <i>Leptospira</i> isolates. by Tetsuya Kakita (4922584)

Immunofluorescence analysis using dual staining for E-cadherin (E-cad) and afadin and F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. by Tetsuya Kakita (4922584)

CK8 knockdown and ROCK1 inhibitor suppressed rTsSPc-induced disruption of the Caco-2 monolayer and blocked rTsSPc-promoted IIL invasion. by Wen Wen Zheng (17721404)

P2X7 modulates migration and the epithelial-mesenchymal phenotype. by José David Nuñez-Ríos (18823719)

Changes in TEER and permeability of EA.hy926 cells exposed to EVs or pellets from infected or uninfected macrophages. by Myriam Lucia Velandia-Romero (8259726)

Expression and functionality of efflux transporters. by Maj Schneider Thomsen (10297019)

Expression of tight junction proteins. by Maj Schneider Thomsen (10297019)

Kinetics and dose response of distinct changes to HDMEC barriers induced by TNF and IL-β. by Paul R. Clark (714064)

“…A plot of the percent increase over basal TEER values (measured at the peak of the TNF-induced TEER increase, mean 0.7±0.01 hours; y-axis) vs. basal TEER (reported in ohms and read on a 96W20idf ECIS array; x-axis). …”

The sera obtained from the patients with t-CIDP, MADSAM and DADS disrupted the BNB. by Fumitaka Shimizu (545145)

“…Normal: conditioned medium with 10% sera obtained from a healthy volunteer diluted with non-conditioned medium of DMEM containing 10% FBS.…”

The effects of MS patients' sera on the tight junction proteins and adhesion molecules in TY09 cells. by Fumitaka Shimizu (545145)

“…Control: non-conditioned DMEM containing 20% FBS; SPMS: conditioned medium with 10% serum from an SPMS patient diluted with non-conditioned DMEM containing 10% FBS; RRMS-R: conditioned medium with a 10% concentration of serum from an RRMS-R patient diluted with non-conditioned DMEM containing 10% FBS; RRMS-S: conditioned medium with a 10% concentration of serum from an RRMS-S patient diluted with non-conditioned DMEM containing 10% FBS; Normal: conditioned medium with 10% serum from a healthy control diluted with non-conditioned medium of DMEM containing 10% FBS.…”